Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 4:05 pm Sale | 2024-11-30 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 0 0.000% | -357,880 (Position Closed) | Filing History |
| 2024-01-22 3:44 pm Purchase | 2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 357,880 14.600% | 357,880 (New Position) | Filing History |
| 2023-02-14 09:30 am Unchanged | 2022-12-31 | 13G | Cue Biopharma, Inc. CUE | Slate Path Capital LP | 2,402,455 5.600% | 0 (Unchanged) | Filing History |
| 2023-02-14 09:30 am Sale | 2022-12-31 | 13G | Stitch Fix, Inc. SFIX | Slate Path Capital LP | 0 0.000% | -4,282,056 (Position Closed) | Filing History |
| 2023-01-13 4:30 pm Unchanged | 2022-11-01 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 357,880 16.500% | 0 (Unchanged) | Filing History |
| 2022-11-18 4:04 pm Purchase | 2022-11-16 | 13G | Cue Biopharma, Inc. CUE | Slate Path Capital LP | 2,402,455 5.600% | 2,402,455 (New Position) | Filing History |
| 2022-10-21 5:13 pm Unchanged | 2022-10-21 | 13D | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 357,880 16.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:15 pm Purchase | 2021-12-31 | 13G | Zimmer Energy Transition Acquisition Corp. ZT | Slate Path Capital LP | 2,000,000 5.800% | 2,000,000 (New Position) | Filing History |
| 2022-02-11 4:44 pm Sale | 2021-12-31 | 13G | Warner Music Group Corp. WMG | Slate Path Capital LP | 3,134,779 2.550% | -1,355,221 (-30.18%) | Filing History |
| 2022-02-11 4:43 pm Purchase | 2021-12-31 | 13G | Hippo Holdings Inc. HIPO | Slate Path Capital LP | 14,000 0.060% | 14,000 (New Position) | Filing History |
| 2022-02-11 4:41 pm Purchase | 2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 357,880 16.490% | 48,077 (+15.52%) | Filing History |
| 2022-02-11 4:40 pm Purchase | 2021-12-31 | 13G | Stitch Fix, Inc. SFIX | Slate Path Capital LP | 4,282,056 5.140% | 4,282,056 (New Position) | Filing History |
| 2022-02-11 4:39 pm Purchase | 2020-12-31 | 13G | 5:01 Acquisition Corp. FVAM | Slate Path Capital LP | 500,000 5.800% | 500,000 (New Position) | Filing History |
| 2021-02-16 07:03 am Purchase | 2020-12-31 | 13G | Warner Music Group Corp. WMG | Slate Path Capital LP | 4,490,000 5.070% | 4,490,000 (New Position) | Filing History |
| 2021-02-16 07:03 am Purchase | 2020-12-31 | 13G | REINVENT TECHNOLOGY PARTNERS Z RTPZU | Slate Path Capital LP | 1,750,000 7.610% | 1,750,000 (New Position) | Filing History |
| 2020-08-10 4:16 pm Purchase | 2020-07-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Slate Path Capital LP | 309,803 18.300% | 309,803 (New Position) | Filing History |